Taking people in Hong KongNo phase
Follow-up study of the Essential Pro device in coronary artery disease patients
Checks the device's safety in adults with narrowed heart arteries.
Plain-language title generated from the registry record
Registry title: Essential Pro Study ( rEPIC04E-HK )
Key facts
- Where
- Lai Chi Kok, Hong KongSee the site
Where in Hong Kong
- Princess Margaret HospitalLai Chi Kok, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundación EPIC
- Trial code
- NCT06631157
- Record updated
- 17 February 2026
- Original description
Single center, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Essential Pro to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Essential Pro.Read full original descriptionShow less
Essential Pro Post-Market Clinical Follow-up Study
Single center, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Essential Pro to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Essential Pro.
Inclusion: Patient treated with Essential Pro according to routine hospital practice and following instructions for use; Informed consent signed.
Exclusion: Not meet inclusion criteria.